DANIPHARM A/S: Financial statements 2018
CVR: 12335040
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 35,699,249 and a net result of DKK 10,231,404 compared with DKK 11,319,150 the year before. That is a decrease of 3.6% compared with the year before. Equity in the 2018 report amounted to DKK 24,832,523. The solvency ratio was 68.3%. The company had 22 employees in the financial year.
- Gross Profit
- DKK 35,699,249
- Profit/Loss
- DKK 10,231,404
- Equity
- DKK 24,832,523
- Total Assets
- DKK 36,363,006
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 35.7 mio. | 10.2 mio. | 24.8 mio. | 22 |
| 2017 | 93.6 mio. | 37 mio. | 11.3 mio. | 50.6 mio. | 26 |
| 2016 | 85.2 mio. | 40.9 mio. | 15.2 mio. | 41.8 mio. | 22 |
| 2015 | 85.1 mio. | 34.9 mio. | 11.3 mio. | 26.5 mio. | 23 |
| 2014 | 90.1 mio. | 30.9 mio. | 8.9 mio. | 15.3 mio. | 23 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.